image
Consumer Defensive - Household & Personal Products - NYSE - US
$ 21.5795
-0.647 %
$ 41.4 B
Market Cap
39.24
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jan, 31, 2025.

The intrinsic value of one KVUE stock under the worst case scenario is HIDDEN Compared to the current market price of 21.6 USD, Kenvue Inc. is HIDDEN

This DCF valuation model was last updated on Jan, 31, 2025.

The intrinsic value of one KVUE stock under the base case scenario is HIDDEN Compared to the current market price of 21.6 USD, Kenvue Inc. is HIDDEN

This DCF valuation model was last updated on Jan, 31, 2025.

The intrinsic value of one KVUE stock under the best case scenario is HIDDEN Compared to the current market price of 21.6 USD, Kenvue Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
15.4 B REVENUE
3.30%
2.51 B OPERATING INCOME
-6.09%
1.66 B NET INCOME
-20.27%
3.17 B OPERATING CASH FLOW
25.47%
-488 M INVESTING CASH FLOW
-25.13%
-2.53 B FINANCING CASH FLOW
-59.63%
3.9 B REVENUE
-2.52%
654 M OPERATING INCOME
-8.66%
383 M NET INCOME
560.34%
249 M OPERATING CASH FLOW
-43.41%
-56 M INVESTING CASH FLOW
34.12%
-162 M FINANCING CASH FLOW
66.94%
Balance Sheet Kenvue Inc.
image
Current Assets 6.14 B
Cash & Short-Term Investments 1.38 B
Receivables 2.07 B
Other Current Assets 2.68 B
Non-Current Assets 21.7 B
Long-Term Investments 71 M
PP&E 2.18 B
Other Non-Current Assets 19.5 B
Current Liabilities 5.48 B
Accounts Payable 2.49 B
Short-Term Debt 643 M
Other Current Liabilities 2.35 B
Non-Current Liabilities 11.2 B
Long-Term Debt 7.78 B
Other Non-Current Liabilities 3.38 B
EFFICIENCY
Earnings Waterfall Kenvue Inc.
image
Revenue 15.4 B
Cost Of Revenue 6.8 B
Gross Profit 8.64 B
Operating Expenses 6.13 B
Operating Income 2.51 B
Other Expenses 848 M
Net Income 1.66 B
RATIOS
55.96% GROSS MARGIN
55.96%
16.27% OPERATING MARGIN
16.27%
10.77% NET MARGIN
10.77%
14.84% ROE
14.84%
5.97% ROA
5.97%
8.29% ROIC
8.29%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Kenvue Inc.
image
Net Income 1.66 B
Depreciation & Amortization 627 M
Capital Expenditures -469 M
Stock-Based Compensation 188 M
Change in Working Capital 797 M
Others 20 M
Free Cash Flow 2.7 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Kenvue Inc.
image
Wall Street analysts predict an average 1-year price target for KVUE of $22.6 , with forecasts ranging from a low of $18 to a high of $27 .
KVUE Lowest Price Target Wall Street Target
18 USD -16.59%
KVUE Average Price Target Wall Street Target
22.6 USD 4.60%
KVUE Highest Price Target Wall Street Target
27 USD 25.12%
4. DIVIDEND ANALYSIS
0.89% DIVIDEND YIELD
0.205 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Kenvue Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 year ago
Aug 30, 2023
Bought 129 K USD
ALLISON RICHARD E JR
Director
+ 5598
22.9589 USD
1 year ago
May 11, 2023
Bought 525 K USD
ALLISON RICHARD E JR
Director
+ 20000
26.2616 USD
7. News
These Dividend Stocks Fell Between 1% and 20% in 2024. Here's Why They Are Too Cheap to Ignore and Worth Buying in 2025. 2024 was a phenomenal year for broader indexes like the S&P 500 and Nasdaq Composite. But not all stocks joined the party. fool.com - 1 week ago
JPMorgan Analyst Focus List Includes 5 of Our Favorite High-Yield Dividend Giants Investors love dividend stocks, especially the high-yield variety, because they offer a significant income stream and have massive total return potential. 247wallst.com - 1 week ago
4 High-Yield Dividend Kings Baby Boomers Count on for Safe Passive Income With the youngest baby boomers (Americans born between 1946 and 1964) approaching retirement age, it's becoming increasingly important to focus on magnificent dividend stocks that will supply significant passive income either in or out of designated retirement accounts like IRAs. 247wallst.com - 1 week ago
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever Being a long-term investor brings a unique peace of mind. It requires thinking in decades, not months or years, which allows an investor to focus on owning exceptional businesses. fool.com - 2 weeks ago
Kenvue Declares Quarterly Cash Dividend SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on Kenvue's common stock. This quarterly dividend is payable on February 26, 2025, to shareholders of record as of the close of business on February 12, 2025. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID®. businesswire.com - 2 weeks ago
Buy 3 'Safer' Dividend Kings Of 25 From 53 For January “A Dividend King [is] a stock with 50 or more consecutive years of dividend increases.”—suredividend.com. 53 Divided Kings, screened as of January 10, 2025, represented all eleven Morningstar Sectors. Broker-estimated top-ten net-gains ranged 22.84%-62.53% topped-by SJW & SCL. By yield, MO topped all the Kings. Top-ten Yields from KVUE, SWK, UBSI, FTS, FRT, BKH, NWN, CDUAF, UVV, & MO, averaged 5.04%. seekingalpha.com - 2 weeks ago
Will Kenvue (KVUE) Beat Estimates Again in Its Next Earnings Report? Kenvue (KVUE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. zacks.com - 2 weeks ago
Buy 1 January S&P 500 Dividend Aristocrat Out Of 38 'Safer' **Investment Thesis:** January's top-yielding Aristocrats include Franklin Resources, Realty Income, Amcor, Kenvue, and Hormel, offering dividends from $1K investments exceeding single share prices. **Rating Justification:** Six more Aristocrats could meet the ideal dividend-to-price ratio with a 45.4% market downturn, making them fair-priced investment opportunities. **Analyst Projections:** Top-ten Aristocrats are expected to deliver 22% to 33.36% net gains by January 2025, with an average net gain of 24.96%. seekingalpha.com - 3 weeks ago
Jefferies Top 2025 Stock Picks Include 5 Sizzling Large Cap Dividend Blue Chips As the calendar turns over to 2025, the leading Wall Street firms are releasing their top stock picks for the new year. 247wallst.com - 4 weeks ago
3 Dividend-Paying Value Stocks to Buy Even If There's a Stock Market Sell-Off in 2025 Investors worried about a stock market sell-off may feel the urge to sell out of their positions and run for the exits. But long-term investors know that it's a mistake to overhaul your investing strategy based on emotion. fool.com - 1 month ago
A Bull Market Is Here: 2 Super Stocks Down 21% and 30% to Buy Right Now Even with the recent bout of market volatility, 2024 has been a fantastic year for stocks. The S&P 500 index has delivered a dividend-adjusted total return of roughly 25% across this year's trading. fool.com - 1 month ago
Buy 6 December Dividend Kings But Watch 22 With 'Safer' Dividends "A Dividend King [is] a stock with 50 or more consecutive years of dividend increases." - suredividend.com. 53 Divided Kings, screened as of December 11, 2024, represented all eleven Morningstar Sectors. Broker-estimated top-ten net gains ranged from 14.79% to 25.23%, topped by SJW and SWK. By yield, MO topped all the Kings. Top-ten yields from ABBV, ADM, SWK, FRT, FTS, BKH, NWN, CDUAF, UVV, and MO averaged 4.67%. seekingalpha.com - 1 month ago
8. Profile Summary

Kenvue Inc. KVUE

image
COUNTRY US
INDUSTRY Household & Personal Products
MARKET CAP $ 41.4 B
Dividend Yield 0.89%
Description Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Contact 199 Grandview Road, Skillman, NJ, 08558 https://www.kenvue.com
IPO Date May 4, 2023
Employees 22000
Officers Ms. Heather R. Howlett Chief Accounting Officer Ms. Meredith Stevens Chief Operations Officer Mr. Carlton Lawson Group President of EMEA & Latin America Ms. Ellie Bing Xie Group President of Asia Pacific Mr. Bernardo Tavares Chief Data & Technology Officer Dr. Caroline Tillett Ph.D. Chief Scientific Officer Mr. Thibaut Mongon Chief Executive Officer & Director Ms. Tina Romani Head of Investor Relations Mr. Paul Ruh Chief Financial Officer Mr. Matthew Orlando General Counsel